Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
Shalabi H, Qin H, Su A, Yates B, Wolters PL, Steinberg SM, Ligon JA, Silbert S, DéDé K, Benzaoui M, Goldberg S, Achar S, Schneider D, Shahani SA, Little L, Foley T, Molina JC, Panch S, Mackall CL, Lee DW, Chien CD, Pouzolles M, Ahlman M, Yuan CM, Wang HW, Wang Y, Inglefield J, Toledo-Tamula MA, Martin S, Highfill SL, Altan-Bonnet G, Stroncek D, Fry TJ, Taylor N, Shah NN. Shalabi H, et al. Among authors: molina jc. Blood. 2022 Aug 4;140(5):451-463. doi: 10.1182/blood.2022015795. Blood. 2022. PMID: 35605184 Free PMC article. Clinical Trial.
CAR T cells better than BiTEs.
Molina JC, Shah NN. Molina JC, et al. Blood Adv. 2021 Jan 26;5(2):602-606. doi: 10.1182/bloodadvances.2020003554. Blood Adv. 2021. PMID: 33496756 Free PMC article. No abstract available.
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
Mikkilineni L, Yates B, Steinberg SM, Shahani SA, Molina JC, Palmore T, Lee DW, Kaplan RN, Mackall CL, Fry TJ, Gea-Banacloche J, Jerussi T, Nussenblatt V, Kochenderfer JN, Shah NN. Mikkilineni L, et al. Among authors: molina jc. Blood Adv. 2021 Dec 14;5(23):5312-5322. doi: 10.1182/bloodadvances.2021004896. Blood Adv. 2021. PMID: 34619768 Free PMC article. Review.
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.
Holland EM, Yates B, Ling A, Yuan CM, Wang HW, Stetler-Stevenson M, LaLoggia M, Molina JC, Lichtenstein DA, Lee DW, Ligon JA, Shalabi H, Ahlman MA, Shah NN. Holland EM, et al. Among authors: molina jc. Blood Adv. 2022 Apr 12;6(7):2167-2182. doi: 10.1182/bloodadvances.2021006035. Blood Adv. 2022. PMID: 34920453 Free PMC article.
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation.
Holland EM, Molina JC, Dede K, Moyer D, Zhou T, Yuan CM, Wang HW, Stetler-Stevenson M, Mackall C, Fry TJ, Panch S, Highfill S, Stroncek D, Little L, Lee DW, Shalabi H, Yates B, Shah N. Holland EM, et al. Among authors: molina jc. J Immunother Cancer. 2022 May;10(5):e004483. doi: 10.1136/jitc-2021-004483. J Immunother Cancer. 2022. PMID: 35534047 Free PMC article.
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.
Molina JC, Li Y, Otto WR, Miller TP, Getz KD, Mccoubrey C, Ramos M, Krause E, Cao L, Gramatges MM, Rabin K, Scheurer M, Elgarten CW, Myers RM, Seif AE, Fisher BT, Shah NN, Aplenc R. Molina JC, et al. Pediatr Blood Cancer. 2023 Jan;70(1):e30062. doi: 10.1002/pbc.30062. Epub 2022 Nov 12. Pediatr Blood Cancer. 2023. PMID: 36370087 Free PMC article.
194 results